CompareOpen in Google Play
This app isn't in any of our charts yet.
Bug fixes and performance improvements.
This app is for registered study participants of GSK BLISSc-ILD only
This app has been created exclusively for participants in the medical study for GSK BLISSc-ILD. It contains Televisit functionality and allows participants to complete questionnaires. A Phase 2/3, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of belimumab administered subcutaneously in adults with systemic sclerosis associated interstitial lung disease (SSc-ILD).
past month, based on 1 day
Downloads
Low confidence3
From install count ÷ months since release
In-app revenue
$0
No in-app purchases
Ads
$0
No ads
Total
$0
In-app + ads
Google Play only. Downloads from daily Top free ranks (or the store's install count); in-app revenue from Top grossing ranks, calibrated on AppTweak's US estimates, or else from downloads; ads from public ad benchmarks. Not reported figures.